117 related articles for article (PubMed ID: 15667548)
1. The co-expression of PML/RAR alpha and AML1/ETO fusion genes is associated with ATRA resistance.
Abreu e Lima RS; Baruffi MR; de Lima AS; de Oliveira FM; de Figueiredo-Pontes LL; Tone LG; Rogatto SR; Falcao RP; Ferrari Chauffaille Mde L; Rego EM
Br J Haematol; 2005 Feb; 128(3):407-9. PubMed ID: 15667548
[No Abstract] [Full Text] [Related]
2. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.
Tabe Y; Konopleva M; Kondo Y; Contractor R; Jin L; Ruvolo V; Tsutsumi-Ishii Y; Miyake K; Miyake N; Ohsaka A; Nagaoka I; Issa JP; Andreeff M
Ann Hematol; 2006 Oct; 85(10):689-704. PubMed ID: 16832676
[TBL] [Abstract][Full Text] [Related]
3. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
[TBL] [Abstract][Full Text] [Related]
4. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.
Imaizumi M; Suzuki H; Yoshinari M; Sato A; Saito T; Sugawara A; Tsuchiya S; Hatae Y; Fujimoto T; Kakizuka A; Konno T; Iinuma K
Blood; 1998 Jul; 92(2):374-82. PubMed ID: 9657734
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
7. Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance.
Zayed A; Couban S; Hayne O; Sparavalo N; Shawwa A; Sadek I; Greer W
Leuk Lymphoma; 2007 Mar; 48(3):489-96. PubMed ID: 17454588
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
9. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel PML-RARG fusion in acute promyelocytic leukemia.
Ha JS; Do YR; Ki CS; Lee C; Kim DH; Lee W; Ryoo NH; Jeon DS
Leukemia; 2017 Sep; 31(9):1992-1995. PubMed ID: 28555082
[No Abstract] [Full Text] [Related]
11. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
Rashidi A; Fisher SI
Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
[No Abstract] [Full Text] [Related]
12. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
[TBL] [Abstract][Full Text] [Related]
13. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Dejean A
Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
[TBL] [Abstract][Full Text] [Related]
14. ATRA(ouble) in the treatment of acute promyelocytic leukemia.
Ozpolat B; Lopez-Berestein G; Mehta K
J Biol Regul Homeost Agents; 2001; 15(2):107-22. PubMed ID: 11501968
[TBL] [Abstract][Full Text] [Related]
15. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?
Subramaniyam S; Nandula SV; Nichols G; Weiner M; Satwani P; Alobeid B; Bhagat G; Murty VV
Leukemia; 2006 Dec; 20(12):2193-5. PubMed ID: 17008891
[No Abstract] [Full Text] [Related]
16. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
19. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.
Minucci S; Maccarana M; Cioce M; De Luca P; Gelmetti V; Segalla S; Di Croce L; Giavara S; Matteucci C; Gobbi A; Bianchini A; Colombo E; Schiavoni I; Badaracco G; Hu X; Lazar MA; Landsberger N; Nervi C; Pelicci PG
Mol Cell; 2000 May; 5(5):811-20. PubMed ID: 10882117
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid as a single agent induces complete remission in a patient with acute leukemia of M2a subtype.
Chen Z; Wang Y; Wang W; Gong J; Xue Y
Chin Med J (Engl); 2002 Jan; 115(1):58-61. PubMed ID: 11930660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
